Effects of Cannabinor, a Novel Selective Cannabinoid 2 Receptor Agonist, on Bladder Function in Normal Rats

European Urology

Volumn 57, Issue 6, 2010, Pages 1093-1100

  Gratzke, Christian ^a,b,f   Streng, Tomi ^c   Stief, Christian G ^b   Downs, Thomas R ^d   Alroy, Iris ^e   Rosenbaum, Jan S ^d   Andersson, Karl Erik ^f   Hedlund, Petter ^a,g  

^a LUND UNIVERSITY   (Sweden)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c TURKU UNIVERSITY   (Finland)

^d Women's Health   (United States)

^e PHARMOS LTD   (Israel)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Cannabinoid; Cystometry; Detrusor; Sensory; Urothelium

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID 2 RECEPTOR AGONIST; CANNABINOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER FUNCTION; CELL STRAIN HEK293; CHOLINERGIC NERVE; DETRUSOR MUSCLE; DRUG SELECTIVITY; FEMALE; IN VIVO STUDY; MICTURITION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SENSORY NERVE; URINARY FREQUENCY; URINE FLOW RATE; URINE VOLUME; URODYNAMICS; UROTHELIUM;

ANIMALS; CANNABINOIDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2; SENSORY RECEPTOR CELLS; URINARY BLADDER; URINATION; URODYNAMICS; UROTHELIUM;

EID: 77951652804     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.02.027     Document Type: Article

References (26)

1. Freeman R.M., Adekanmi O., Waterfield M.R., et al. The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS). Int Urogynecol J Pelvic Floor Dysfunct 17 (2006) 636-641
2. Brady C.M., DasGupta R., Dalton C., et al. An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. Mult Scler 10 (2004) 425-433
3. Jaggar S.I., Sellaturay S., and Rice A.S. The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder. Neurosci Lett 253 (1998) 123-126
4. Dmitrieva N., and Berkley K.J. Contrasting effects of WIN 55212-2 on motility of the rat bladder and uterus. J Neurosci 22 (2002) 7147-7153
5. Gratzke C., Streng T., Park A., et al. Distribution and function of cannabinoid receptors 1 and 2 in the rat, monkey and human bladder. J Urol 181 (2009) 1939-1948
6. Howlett A.C., Barth F., Bonner T.I., et al. International Union of Pharmacology, XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54 (2002) 161-202
7. Guindon J., and Hohmann A.G. A physiological role for endocannabinoid-derived products of cyclooxygenase-2-mediated oxidative metabolism. Br J Pharmacol 153 (2008) 1341-1343
8. Pertwee R.G., and Fernando S.R. Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br J Pharmacol 118 (1996) 2053-2058
9. Martin R.S., Luong L.A., Welsh N.J., et al. Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human. Br J Pharmacol 129 (2000) 1707-1715
10. Tyagi V., Philips B.J., Su R., et al. Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium. J Urol 181 (2009) 1932-1938
11. Hayn M.H., Ballesteros I., de Miguel F., et al. Functional and immunohistochemical characterization of CB1 and CB2 receptors in rat bladder. Urology 72 (2008) 1174-1178
12. Streng T., Axelsson H.E., Hedlund P., et al. Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. Eur Urol 53 (2008) 391-400
13. Hedlund H., Andersson K.E., and Mattiasson A. Pre- and postjunctional adreno- and muscarinic receptor functions in the isolated human corpus spongiosum urethrae. J Auton Pharmacol 4 (1984) 241-249
14. Lee T., Andersson K.E., Streng T., and Hedlund P. Simultaneous registration of intraabdominal and intravesical pressures during cystometry in conscious rats-effects of bladder outlet obstruction and intravesical PGE2. Neurourol Urodyn 27 (2008) 88-95
15. Hiragata S., Ogawa T., Hayashi Y., et al. Effects of IP-751, ajulemic acid, on bladder overactivity induced by bladder irritation in rats. Urology 70 (2007) 202-208
16. Walczak J.S., Price T.J., and Cervero F. Cannabinoid CB1 receptors are expressed in the mouse urinary bladder and their activation modulates afferent bladder activity. Neuroscience 159 (2009) 1154-1163
17. Weinhold P., Gratzke C., Streng T., et al. TRPA1-receptor-induced relaxation of the human urethra involves TRPV1- and cannabinoid-receptor-mediated signals and activation of cyclooxygenase. J Urol 183 (2010) 2070-2076
18. Buckley N.E. The peripheral cannabinoid receptor knockout mice: an update. Br J Pharmacol 153 (2008) 309-318
19. Nackley A.G., Suplita R.L., and Hohmann A.G. A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience 117 (2003) 659-670
20. Nackley A.G., Zvonok A.M., Makriyannis A., and Hohmann A.G. Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation. J Neurophysiol 92 (2004) 3562-3574
21. Elmes S.J., Jhaveri M.D., Smart D., et al. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain. Eur J Neurosci 20 (2004) 2311-2320
22. Patel H.J., Birrell M.A., Crispino N., et al. Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation. Br J Pharmacol 140 (2003) 261-268
23. Belvisi M.G., Patel H.J., Freund-Michel V., et al. Inhibitory activity of the novel CB2 receptor agonist, GW833972A, on guinea-pig and human sensory nerve function in the airways. Br J Pharmacol 155 (2008) 547-557
24. Wilkinson J.D., Kendall D.A., and Ralevic V. Delta 9-tetrahydrocannabinol inhibits electrically-evoked CGRP release and capsaicin-sensitive sensory neurogenic vasodilatation in the rat mesenteric arterial bed. Br J Pharmacol 152 (2007) 709-716
25. Sagar D.R., Kelly S., Millns P.J., et al. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. Eur J Neurosci 22 (2005) 371-379
26. Anand U., Otto W.R., Sanchez-Herrera D., et al. Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons. Pain 138 (2008) 667-680